Low-dose temozolomide modulation of peripheral blood regulatory T cells before dendritic cell-based vaccination in metastatic melanoma: Phase I/II study

被引：0
|
作者：
Ridolfi, L.
Fiammenghi, L.
Petrini, M.
Granato, A.
Ancarani, V.
Pancisi, E.
Guidoboni, M.
Riccobon, A.
Ascierto, P. A.
Ridolfi, R.
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy
[2] Ist Nazl Tumori Pascale, Naples, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS311
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of low-dose cyclophosphamide, tumor-associated peptide antigen-pulsed dendritic cell and low dose GM-CSF for solid and hematological tumors.
    Mirandola, Leonardo
    Figueroa, Jose A.
    Diane Duyen Thuy Nguyen
    Dahlbeck, Scott
    Chiriva-Internati, Maurizio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [42] FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study
    Morganti, Alessio G.
    Mignogna, Samantha
    Caravatta, Luciana
    Deodato, Francesco
    Macchia, Gabriella
    Plantamura, Nunzio M.
    Massaccesi, Mariangela
    Picardi, Vincenzo
    Cilla, Savino
    Valentini, Vincenzo
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (06) : 353 - 358
  • [43] PHASE-I-II STUDY OF LOW-DOSE INTRAVENOUS OKT3 AND SUBCUTANEOUS INTERLEUKIN-2 IN METASTATIC CANCER
    BUTER, J
    JANSSEN, RAJ
    MARTENS, A
    SLEIJFER, DT
    DELEIJ, L
    MULDER, NH
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (15) : 2108 - 2113
  • [44] A phase I/II study of Xcellerated T cells after autologous peripheral blood stem cell transplantation in patients with multiple myeloma.
    Borrello, IM
    Vij, R
    Vescio, RA
    Martin, TG
    Siegel, D
    Berenson, JR
    Janmohamed, F
    Bonyhadi, M
    Berenson, RJ
    Frohlich, MW
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 173S - 173S
  • [45] A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma.
    Vij, R
    Borrello, IM
    Martin, T
    Vescio, R
    Siegel, D
    Bashey, A
    DiPersio, JF
    Berenson, J
    Ferrand, C
    Janmohamed, F
    Yuan, V
    Bouchard, L
    Berenson, RJ
    Bonyhadi, M
    Frohlich, MW
    BLOOD, 2003, 102 (11) : 43A - 43A
  • [46] A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma.
    Siegel, D
    Vij, R
    Vescio, RA
    Borrello, IM
    Martin, TG
    Berenson, JR
    Ferrand, C
    Janmohamed, F
    Berenson, RJ
    Frohlich, MW
    BLOOD, 2004, 104 (11) : 265A - 265A
  • [47] In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study
    F Bonifazi
    G Bandini
    M Stanzani
    F Palandri
    B Giannini
    M Arpinati
    G Rosti
    M Baccarani
    Bone Marrow Transplantation, 2005, 35 : 1025 - 1026
  • [48] In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML:: results from a prospective phase II study
    Bonifazi, F
    Bandini, G
    Stanzani, M
    Palandri, F
    Giannini, B
    Arpinati, M
    Rosti, G
    Baccarani, M
    BONE MARROW TRANSPLANTATION, 2005, 35 (10) : 1025 - 1026
  • [49] Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial
    Angela Märten
    Dimitri Flieger
    Sabine Renoth
    Silvia Weineck
    Peter Albers
    Markus Compes
    Björn Schöttker
    Carsten Ziske
    Steffen Engelhart
    Peter Hanfland
    Ludmila Krizek
    Cora Faber
    Alexander von Ruecker
    Stefan Müller
    Tilman Sauerbruch
    Ingo G. Schmidt-Wolf
    Cancer Immunology, Immunotherapy, 2002, 51 : 637 - 644
  • [50] Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells:: preclinical results and outcome of a first clinical phase I/II trial
    Märten, A
    Flieger, D
    Renoth, S
    Weineck, S
    Albers, P
    Compes, M
    Schöttker, B
    Ziske, C
    Engelhart, S
    Hanfland, P
    Krizek, L
    Faber, C
    von Ruecker, A
    Müller, S
    Sauerbruch, T
    Schmidt-Wolf, IGH
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (11-12) : 637 - 644
12345